AbbVie Inc. (ABBV)
ABBV price $284.72 -4.36 -1.51%
- Ticker
- ABBV
- Price
- $284.72
- Change
- -4.36 -1.51%
- Market cap
- $503.13B
- P/E
- 81.42
- Forward P/E
- 20.41
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stocklytics score
- 56
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in…